0
     

Report Added
Report already added
Cefotaxime Sodium API Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Cefotaxime Sodium API Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Cefotaxime sodium is the sodium salt form of cefotaxime, a beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Cefotaxime sodium binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linking of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. Compared to the second and first generation cephalosporins, cefotaxime sodium is more active against gram-negative bacteria and less active against gram-positive bacteria.

This report contains market size and forecasts of Cefotaxime Sodium API in India, including the following market information:
India Cefotaxime Sodium API Market Revenue, 2015-2020, 2021-2026, ($ millions)
India Cefotaxime Sodium API Market Consumption, 2015-2020, 2021-2026, (MT)
India Cefotaxime Sodium API Production Capacity, 2015-2020, 2021-2026, (MT)
Top Five Competitors in India Cefotaxime Sodium API Market 2019 (%)
The global Cefotaxime Sodium API market was valued at 105.2 million in 2019 and is projected to reach US$ 102 million by 2026, at a CAGR of -0.8% during the forecast period. While the Cefotaxime Sodium API market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cefotaxime Sodium API manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Cefotaxime Sodium API production and consumption in India
Total Market by Segment:
India Cefotaxime Sodium API Market, By Type, 2015-2020, 2021-2026 ($ millions) & (MT)
India Cefotaxime Sodium API Market Segment Percentages, By Type, 2019 (%)
ChP
USP
EP
Chp refers to Chinese Pharmacopoeia. USP refers to the United States Pharmacopeia. EP refers to the European Pharmacopoeia. And the proportion of ChP in 2019 is about 77.92%.

India Cefotaxime Sodium API Market, By Application, 2015-2020, 2021-2026 ($ millions) & (MT)
India Cefotaxime Sodium API Market Segment Percentages, By Application, 2019 (%)
Single Injection
Compound Injection
Cefotaxime sodium API is widely for single injection and compound injection. The proportion of single injection in 2019 is about 76.02%.

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Cefotaxime Sodium API Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)
Total Cefotaxime Sodium API Market Competitors Revenues Share in India, by Players 2019 (%)
Total India Cefotaxime Sodium API Market Competitors Sales, by Players 2015-2020 (Estimated), (MT)
Total India Cefotaxime Sodium API Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
REYOUNG
Nectar Lifesciences
Medya Pharma
Sandoz
Kelun
NCPC
Aurobindo Pharma
United Laboratories
Orchid Pharma
CSPC
Kopran
Covalent
ACS Dobfar
Dawnrays
1 Introduction to Research & Analysis Reports
1.1 Cefotaxime Sodium API Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 India Cefotaxime Sodium API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

2 COVID-19 Impact: India Cefotaxime Sodium API Overall Market Size
2.1 India Cefotaxime Sodium API Market Size: 2020 VS 2026
2.2 India Cefotaxime Sodium API Revenue, Prospects & Forecasts: 2015-2026
2.3 India Cefotaxime Sodium API Sales (Consumption): 2015-2026

3 Company Landscape
3.1 Top Cefotaxime Sodium API Players in India (including Foreign and Local Companies)
3.2 Top India Cefotaxime Sodium API Companies Ranked by Revenue
3.3 India Cefotaxime Sodium API Revenue by Companies (including Foreign and Local Companies)
3.4 India Cefotaxime Sodium API Sales by Companies (including Foreign and Local Companies)
3.5 India Cefotaxime Sodium API Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Cefotaxime Sodium API Companies in India, by Revenue in 2019
3.7 India Manufacturers Cefotaxime Sodium API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cefotaxime Sodium API Players in India
3.8.1 List of India Tier 1 Cefotaxime Sodium API Companies
3.8.2 List of India Tier 2 and Tier 3 Cefotaxime Sodium API Companies

4 Sights by Product
4.1 Overview
4.1.1 By Type - India Cefotaxime Sodium API Market Size Markets, 2020 & 2026
4.1.2 ChP
4.1.3 USP
4.1.4 EP
4.2 By Type - India Cefotaxime Sodium API Revenue & Forecasts
4.2.1 By Type - India Cefotaxime Sodium API Revenue, 2015-2020
4.2.2 By Type - India Cefotaxime Sodium API Revenue, 2021-2026
4.2.3 By Type - India Cefotaxime Sodium API Revenue Market Share, 2015-2026
4.3 By Type - India Cefotaxime Sodium API Sales & Forecasts
4.3.1 By Type - India Cefotaxime Sodium API Sales, 2015-2020
4.3.2 By Type - India Cefotaxime Sodium API Sales, 2021-2026
4.3.3 By Type - India Cefotaxime Sodium API Sales Market Share, 2015-2026
4.4 By Type - India Cefotaxime Sodium API Price (Manufacturers Selling Prices), 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - India Cefotaxime Sodium API Market Size, 2020 & 2026
5.1.2 Single Injection
5.1.3 Compound Injection
5.2 By Application - India Cefotaxime Sodium API Revenue & Forecasts
5.2.1 By Application - India Cefotaxime Sodium API Revenue, 2015-2020
5.2.2 By Application - India Cefotaxime Sodium API Revenue, 2021-2026
5.2.3 By Application - India Cefotaxime Sodium API Revenue Market Share, 2015-2026
5.3 By Application - India Cefotaxime Sodium API Sales & Forecasts
5.3.1 By Application - India Cefotaxime Sodium API Sales, 2015-2020
5.3.2 By Application - India Cefotaxime Sodium API Sales, 2021-2026
5.3.3 By Application - India Cefotaxime Sodium API Sales Market Share, 2015-2026
5.4 By Application - India Cefotaxime Sodium API Price (Manufacturers Selling Prices), 2015-2026
6 Manufacturers & Brands Profiles
6.1 REYOUNG
6.1.1 REYOUNG Corporate Summary
6.1.2 REYOUNG Business Overview
6.1.3 REYOUNG Cefotaxime Sodium API Major Product Offerings
6.1.4 REYOUNG Sales and Revenue in India (2015-2020)
6.1.5 REYOUNG Key News
6.2 Nectar Lifesciences
6.2.1 Nectar Lifesciences Corporate Summary
6.2.2 Nectar Lifesciences Business Overview
6.2.3 Nectar Lifesciences Cefotaxime Sodium API Major Product Offerings
6.2.4 Nectar Lifesciences Sales and Revenue in India (2015-2020)
6.2.5 Nectar Lifesciences Key News
6.3 Medya Pharma
6.3.1 Medya Pharma Corporate Summary
6.3.2 Medya Pharma Business Overview
6.3.3 Medya Pharma Cefotaxime Sodium API Major Product Offerings
6.3.4 Medya Pharma Sales and Revenue in India (2015-2020)
6.3.5 Medya Pharma Key News
6.4 Sandoz
6.4.1 Sandoz Corporate Summary
6.4.2 Sandoz Business Overview
6.4.3 Sandoz Cefotaxime Sodium API Major Product Offerings
6.4.4 Sandoz Sales and Revenue in India (2015-2020)
6.4.5 Sandoz Key News
6.5 Kelun
6.5.1 Kelun Corporate Summary
6.5.2 Kelun Business Overview
6.5.3 Kelun Cefotaxime Sodium API Major Product Offerings
6.5.4 Kelun Sales and Revenue in India (2015-2020)
6.5.5 Kelun Key News
6.6 NCPC
6.6.1 NCPC Corporate Summary
6.6.2 NCPC Business Overview
6.6.3 NCPC Cefotaxime Sodium API Major Product Offerings
6.6.4 NCPC Sales and Revenue in India (2015-2020)
6.6.5 NCPC Key News
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporate Summary
6.6.2 Aurobindo Pharma Business Overview
6.6.3 Aurobindo Pharma Cefotaxime Sodium API Major Product Offerings
6.4.4 Aurobindo Pharma Sales and Revenue in India (2015-2020)
6.7.5 Aurobindo Pharma Key News
6.8 United Laboratories
6.8.1 United Laboratories Corporate Summary
6.8.2 United Laboratories Business Overview
6.8.3 United Laboratories Cefotaxime Sodium API Major Product Offerings
6.8.4 United Laboratories Sales and Revenue in India (2015-2020)
6.8.5 United Laboratories Key News
6.9 Orchid Pharma
6.9.1 Orchid Pharma Corporate Summary
6.9.2 Orchid Pharma Business Overview
6.9.3 Orchid Pharma Cefotaxime Sodium API Major Product Offerings
6.9.4 Orchid Pharma Sales and Revenue in India (2015-2020)
6.9.5 Orchid Pharma Key News
6.10 CSPC
6.10.1 CSPC Corporate Summary
6.10.2 CSPC Business Overview
6.10.3 CSPC Cefotaxime Sodium API Major Product Offerings
6.10.4 CSPC Sales and Revenue in India (2015-2020)
6.10.5 CSPC Key News
6.11 Kopran
6.11.1 Kopran Corporate Summary
6.11.2 Kopran Cefotaxime Sodium API Business Overview
6.11.3 Kopran Cefotaxime Sodium API Major Product Offerings
6.11.4 Kopran Sales and Revenue in India (2015-2020)
6.11.5 Kopran Key News
6.12 Covalent
6.12.1 Covalent Corporate Summary
6.12.2 Covalent Cefotaxime Sodium API Business Overview
6.12.3 Covalent Cefotaxime Sodium API Major Product Offerings
6.12.4 Covalent Sales and Revenue in India (2015-2020)
6.12.5 Covalent Key News
6.13 ACS Dobfar
6.13.1 ACS Dobfar Corporate Summary
6.13.2 ACS Dobfar Cefotaxime Sodium API Business Overview
6.13.3 ACS Dobfar Cefotaxime Sodium API Major Product Offerings
6.13.4 ACS Dobfar Sales and Revenue in India (2015-2020)
6.13.5 ACS Dobfar Key News
6.14 Dawnrays
6.14.1 Dawnrays Corporate Summary
6.14.2 Dawnrays Cefotaxime Sodium API Business Overview
6.14.3 Dawnrays Cefotaxime Sodium API Major Product Offerings
6.14.4 Dawnrays Sales and Revenue in India (2015-2020)
6.14.5 Dawnrays Key News
6.15 Sterile India
6.15.1 Sterile India Corporate Summary
6.15.2 Sterile India Cefotaxime Sodium API Business Overview
6.15.3 Sterile India Cefotaxime Sodium API Major Product Offerings
6.15.4 Sterile India Sales and Revenue in India (2015-2020)
6.15.5 Sterile India Key News

7 Cefotaxime Sodium API Production Capacity, Export and Import Analysis
7.1 Cefotaxime Sodium API Production Capacity and Value in India, Situation Analysis and Prediction, 2015-2026
7.1.1 India Cefotaxime Sodium API Production Capacity, 2015-2026
7.1.2 India Cefotaxime Sodium API Production 2015-2026
7.1.3 India Cefotaxime Sodium API Production Value 2015-2026
7.2 Key Local Cefotaxime Sodium API Manufacturers in India
7.2.1 India Key Local Cefotaxime Sodium API Manufacturers Production Capacity
7.2.2 India Key Local Cefotaxime Sodium API Manufacturers Production
7.2.3 India Key Local Cefotaxime Sodium API Manufacturers Production Value
7.2.4 The Proportion of Cefotaxime Sodium API Production Sold in India and Sold Other Than India by Manufacturers
7.3 Cefotaxime Sodium API Export and Import in India
7.3.1 India Cefotaxime Sodium API Export Market
7.3.2 India Cefotaxime Sodium API Source of Imports

8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints
8.1 PESTLE Analysis for India Cefotaxime Sodium API Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 Impact on Cefotaxime Sodium API Supply Chain Analysis
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Cefotaxime Sodium API Distributors and Sales Agents in India

10 Conclusion

11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
List of Tables
Table 1. Key Players of Cefotaxime Sodium API in India
Table 2. Top Players in India, Ranking by Revenue (2019)
Table 3. India Cefotaxime Sodium API Revenue by Companies, (US$, Mn), 2015-2020
Table 4. India Cefotaxime Sodium API Revenue Share by Companies, 2015-2020
Table 5. India Cefotaxime Sodium API Sales by Companies, (MT), 2015-2020
Table 6. India Cefotaxime Sodium API Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Cefotaxime Sodium API Price (2015-2020) (USD/MT)
Table 8. India Manufacturers Cefotaxime Sodium API Product Type
Table 9. List of India Tier 1 Cefotaxime Sodium API Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of India Tier 2 and Tier 3 Cefotaxime Sodium API Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Cefotaxime Sodium API Revenue in India (US$, Mn), 2015-2020
Table 12. By Type - Cefotaxime Sodium API Revenue in India (US$, Mn), 2021-2026
Table 13. By Type - Cefotaxime Sodium API Sales in India (MT), 2015-2020
Table 14. By Type - Cefotaxime Sodium API Sales in India (MT), 2021-2026
Table 15. By Application - Cefotaxime Sodium API Revenue in India, (US$, Mn), 2015-2020
Table 16. By Application - Cefotaxime Sodium API Revenue in India, (US$, Mn), 2021-2026
Table 17. By Application - Cefotaxime Sodium API Sales in India, (MT), 2015-2020
Table 18. By Application - Cefotaxime Sodium API Sales in India, (MT), 2021-2026
Table 19. REYOUNG Corporate Summary
Table 20. REYOUNG Cefotaxime Sodium API Product Offerings
Table 21. REYOUNG Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 22. Nectar Lifesciences Corporate Summary
Table 23. Nectar Lifesciences Cefotaxime Sodium API Product Offerings
Table 24. Nectar Lifesciences Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 25. Medya Pharma Corporate Summary
Table 26. Medya Pharma Cefotaxime Sodium API Product Offerings
Table 27. Medya Pharma Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 28. Sandoz Corporate Summary
Table 29. Sandoz Cefotaxime Sodium API Product Offerings
Table 30. Sandoz Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 31. Kelun Corporate Summary
Table 32. Kelun Cefotaxime Sodium API Product Offerings
Table 33. Kelun Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 34. NCPC Corporate Summary
Table 35. NCPC Cefotaxime Sodium API Product Offerings
Table 36. NCPC Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 37. Aurobindo Pharma Corporate Summary
Table 38. Aurobindo Pharma Cefotaxime Sodium API Product Offerings
Table 39. Aurobindo Pharma Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 40. United Laboratories Corporate Summary
Table 41. United Laboratories Cefotaxime Sodium API Product Offerings
Table 42. United Laboratories Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 43. Orchid Pharma Corporate Summary
Table 44. Orchid Pharma Cefotaxime Sodium API Product Offerings
Table 45. Orchid Pharma Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 46. CSPC Corporate Summary
Table 47. CSPC Cefotaxime Sodium API Product Offerings
Table 48. CSPC Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 49. Kopran Corporate Summary
Table 50. Kopran Cefotaxime Sodium API Product Offerings
Table 51. Kopran Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 52. Covalent Corporate Summary
Table 53. Covalent Cefotaxime Sodium API Product Offerings
Table 54. Covalent Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 55. ACS Dobfar Corporate Summary
Table 56. ACS Dobfar Cefotaxime Sodium API Product Offerings
Table 57. ACS Dobfar Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 58. Dawnrays Corporate Summary
Table 59. Dawnrays Cefotaxime Sodium API Product Offerings
Table 60. Dawnrays Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 61. Sterile India Corporate Summary
Table 62. Sterile India Cefotaxime Sodium API Product Offerings
Table 63. Sterile India Cefotaxime Sodium API Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2015-2020)
Table 64. Cefotaxime Sodium API Production Capacity (MT) of Local Manufacturers in India, 2015-2020
Table 65. Cefotaxime Sodium API Production (MT) of Local Manufacturers in India, 2015-2020
Table 66. India Cefotaxime Sodium API Production Market Share of Local Manufacturers, 2015-2020
Table 67. Cefotaxime Sodium API Production Value (US$, Mn) of Local Manufacturers in India, 2015-2020
Table 68. India Cefotaxime Sodium API Production Value Market Share of Local Manufacturers, 2015-2020
Table 69. The Percentage of Cefotaxime Sodium API Production Sold in India and Sold Other Than India by Manufacturers
Table 70. The Percentage of Cefotaxime Sodium API Production Sold in India and Sold Other Than India by Manufacturers
Table 71. Dangeguojia Cefotaxime Sodium API Sales (Consumption), Production, Export and Import, 2015-2020
Table 72. Raw Materials and Suppliers
Table 73. Cefotaxime Sodium API Downstream Clients in India
Table 74. Cefotaxime Sodium API Distributors and Sales Agents in India
List of Figures
Figure 1. Cefotaxime Sodium API Segment by Type
Figure 2. Cefotaxime Sodium API Segment by Application
Figure 3. Dangeguojia Cefotaxime Sodium API Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Cefotaxime Sodium API Market Size in India, (US$, Mn) & (MT): 2020 VS 2026
Figure 6. India Cefotaxime Sodium API Revenue, 2015-2026 (US$, Mn)
Figure 7. Cefotaxime Sodium API Sales in India: 2015-2026 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Cefotaxime Sodium API Revenue in 2019
Figure 9. By Type - India Cefotaxime Sodium API Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - India Cefotaxime Sodium API Market Share, 2015-2020
Figure 11. By Type - India Cefotaxime Sodium API Market Share, 2020-2026
Figure 12. By Type - India Cefotaxime Sodium API Price (USD/MT), 2015-2026
Figure 13. By Application - Cefotaxime Sodium API Revenue in India (US$, Mn), 2020 & 2026
Figure 14. By Application - India Cefotaxime Sodium API Market Share, 2015-2020
Figure 15. By Application - India Cefotaxime Sodium API Market Share, 2020-2026
Figure 16. By Application -India Cefotaxime Sodium API Price (USD/MT), 2015-2026
Figure 17. India Cefotaxime Sodium API Production Capacity (MT), 2015-2026
Figure 18. India Cefotaxime Sodium API Actual Output (MT), 2015-2026
Figure 19. India Cefotaxime Sodium API Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of India Cefotaxime Sodium API Export Destination, 2019
Figure 21. The Source of Imports of India Cefotaxime Sodium API, 2019
Figure 22. PEST Analysis for India Cefotaxime Sodium API Market in 2020
Figure 23. Cefotaxime Sodium API Market Opportunities & Trends in India
Figure 24. Cefotaxime Sodium API Market Drivers in India
Figure 25. Cefotaxime Sodium API Market Restraints in India
Figure 26. Cefotaxime Sodium API Industry Value Chain

Report Title: Cefotaxime Sodium API Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW